Samario Chaitchik

2.8k total citations
125 papers, 2.1k citations indexed

About

Samario Chaitchik is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Samario Chaitchik has authored 125 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Oncology, 31 papers in Molecular Biology and 28 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Samario Chaitchik's work include Immunotherapy and Immune Responses (15 papers), Melanoma and MAPK Pathways (12 papers) and Monoclonal and Polyclonal Antibodies Research (12 papers). Samario Chaitchik is often cited by papers focused on Immunotherapy and Immune Responses (15 papers), Melanoma and MAPK Pathways (12 papers) and Monoclonal and Polyclonal Antibodies Research (12 papers). Samario Chaitchik collaborates with scholars based in Israel, United States and Australia. Samario Chaitchik's co-authors include Ofer Merimsky, Moshe Inbar, Shulamith Kreitler, Yoram Rapoport, Iafa Keydar, Joseph M. Klausner, Kineret Weissler, Ofer Kaplan, Sima Shina and Adit Ben‐Baruch and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Cancer.

In The Last Decade

Samario Chaitchik

125 papers receiving 2.1k citations

Peers

Samario Chaitchik
John Graham‐Pole United States
Joseph Laver United States
Thomas Cerny Switzerland
Bruce G. Ward Australia
Yu Jiang China
Ernest I. Kohorn United States
W. Bergman Netherlands
Luis Isola United States
Edward Pequignot United States
Nancy Lewis United States
John Graham‐Pole United States
Samario Chaitchik
Citations per year, relative to Samario Chaitchik Samario Chaitchik (= 1×) peers John Graham‐Pole

Countries citing papers authored by Samario Chaitchik

Since Specialization
Citations

This map shows the geographic impact of Samario Chaitchik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samario Chaitchik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samario Chaitchik more than expected).

Fields of papers citing papers by Samario Chaitchik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samario Chaitchik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samario Chaitchik. The network helps show where Samario Chaitchik may publish in the future.

Co-authorship network of co-authors of Samario Chaitchik

This figure shows the co-authorship network connecting the top 25 collaborators of Samario Chaitchik. A scholar is included among the top collaborators of Samario Chaitchik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samario Chaitchik. Samario Chaitchik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shimonov, Mordechai, et al.. (2005). Combined Systemic Chronotherapy and Hepatic Artery Infusion for the Treatment of Metastatic Colorectal Cancer Confined to the Liver. Chemotherapy. 51(2-3). 111–115. 14 indexed citations
2.
Ron, Ilan G., Nely Wigler, Riva Borovik, et al.. (2002). CMF (Cyclophosphamide, Methotrexate, 5-Fluorouracil) Versus CNF (Cyclophosphamide, Mitoxantrone, 5-Fluorouracil) as Adjuvant Chemotherapy for Stage II Lymph-Node Positive Breast Cancer. American Journal of Clinical Oncology. 25(5). 520–522. 1 indexed citations
3.
Ron, Ilan G., Nely Wigler, Riva Borovik, et al.. (2001). CMF (Cyclophosphamide, Methotrexate, 5-Fluorouracil) Versus CNF (Cyclophosphamide, Mitoxantrone, 5-Fluorouracil) as Adjuvant Chemotherapy for Stage II Lymph-Node Positive Breast Cancer. American Journal of Clinical Oncology. 24(4). 323–327. 7 indexed citations
4.
Gutman, Mordechai, Patrick Sorkine, Moshe Inbar, et al.. (1996). Regional perfusion with hemofiltration (chemofiltration) for the treatment of patients with regionally advanced cancer. Cancer. 78(5). 1125–1130. 3 indexed citations
5.
Merimsky, Ofer, et al.. (1996). Malignant Melanoma of the Head and Neck. American Journal of Clinical Oncology. 19(4). 363–367. 8 indexed citations
6.
Ron, Ilan G., et al.. (1996). Kaposi's Sarcoma on a Lymphedematous Arm After Mastectomy. American Journal of Clinical Oncology. 19(1). 87–90. 8 indexed citations
7.
Merimsky, Ofer, Yehuda Shoenfeld, Ehud Baharav, et al.. (1996). Melanoma-Associated Hypopigmentation: Where Are the Antibodies?. American Journal of Clinical Oncology. 19(6). 613–618. 17 indexed citations
8.
Merimsky, Ofer, et al.. (1994). Antigens and Antibodies in Malignant Melanoma. Tumor Biology. 15(4). 188–202. 31 indexed citations
9.
Eisenthal, Avi, et al.. (1993). Antitumor effects of recombinant interleukin-6 expressed in eukaryotic cells. Cancer Immunology Immunotherapy. 36(2). 101–107. 11 indexed citations
10.
Merimsky, Ofer, Irith Reider‐Groswasser, Nely Wigler, & Samario Chaitchik. (1992). Encephalopathy in ifosfamide-treated patients. Acta Neurologica Scandinavica. 86(5). 521–525. 24 indexed citations
11.
Inbar, Moshe, et al.. (1992). Endometrioid carcinoma of the ovary presenting as primary carcinoma of the breast. Acta Obstetricia Et Gynecologica Scandinavica. 71(1). 81–83. 6 indexed citations
12.
Merimsky, Ofer, et al.. (1992). Salvage cisplatin and adriamycin for advanced or recurrent basal or squamous cell carcinoma of the face. Anti-Cancer Drugs. 3(5). 481–484. 19 indexed citations
13.
Chaitchik, Samario, et al.. (1992). Doctor-patient communication in a cancer ward. Journal of Cancer Education. 7(1). 41–54. 96 indexed citations
14.
Merimsky, Ofer, Moshe Inbar, & Samario Chaitchik. (1992). Fotemustine and DTIC Combination in Patients with Disseminated Malignant Melanoma. American Journal of Clinical Oncology. 15(1). 84–86. 4 indexed citations
15.
Chaitchik, Samario & Shulamith Kreitler. (1991). Induced versus spontaneous attendance of breast-screening tests by women. Journal of Cancer Education. 6(1). 43–53. 10 indexed citations
16.
Merimsky, Ofer, et al.. (1990). Pregnancy and cavernous sinus involvement in a patient with primary non-Hodgkin's lymphoma of bone.. PubMed. 26(9). 520–4. 3 indexed citations
17.
Merimsky, Ofer, Irith Reider‐Groswasser, Moshe Inbar, & Samario Chaitchik. (1990). Interferon-related mental deterioration and behavioral changes in patients with renal cell carcinoma. European Journal of Cancer and Clinical Oncology. 26(5). 596–600. 36 indexed citations
18.
Chaitchik, Samario, et al.. (1988). The distribution of selenium in human blood samples of Israeli population—Comparison between normal and breast cancer cases. Biological Trace Element Research. 15(1). 205–212. 16 indexed citations
19.
Menczer, Joseph, Michel Atlas, A. Werner, et al.. (1983). Survival Data of Israeli Jewish Patients with Squamous Cell Carcinoma of the Cervix Treated by Irradiation. Gynecologic and Obstetric Investigation. 15(3). 141–146. 3 indexed citations
20.
Arnon, Ruth, et al.. (1977). Viroimmunoassay utilizing a synthetic peptide: a test equivalent to the carcinoembryonic antigen radioimmunoassay.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 13(10). 1022–7. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026